Africa Western and Central vs Rwanda: Access to anti-retroviral drugs, female
Africa Western and Central
83.1%
in 2024
Rwanda
97.0%
in 2024
Africa Western and Central rank
14th
Rwanda rank
12th
Access to anti-retroviral drugs, female over time
- Africa Western and Central
- Rwanda
How they compare
Rwanda currently reports 97.0% against 83.1% in Africa Western and Central, a difference of 13.9%.
That makes Rwanda's figure about 1.2 times Africa Western and Central's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Rwanda ahead.
Africa Western and Central ranks 14th and Rwanda ranks 12th of 19 groups.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa Western and Central | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.6% | 11.1% | 6.5% | Rwanda |
| 2010s | 40.2% | 63.3% | 23.1% | Rwanda |
| 2020s | 74.6% | 90.8% | 16.2% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Africa Western and Central or Rwanda?
- Rwanda, at 97.0% against 83.1% in Africa Western and Central as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Africa Western and Central and Rwanda?
- 13.9%, with Rwanda ahead.
- How many years of comparable data are there for Africa Western and Central and Rwanda?
- 25 years are reported by both, from 2000 to 2024.
- How do Africa Western and Central and Rwanda rank globally for access to anti-retroviral drugs, female?
- Africa Western and Central ranks 14th and Rwanda ranks 12th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.